GlassScriptPhysician profile
Ryan Richard Sullivan
NPI 1417085606
$5,393.42
in general payments reported to CMS, 2019-2025
34 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,447 · 2020: $995 · 2021: $1,595 · 2022: $320 · 2024: $35.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $35.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $35.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,137.00 | 2019 | |
| Pfizer INC. | $869.45 | 2019-2021 | |
| Abbvie INC. | $544.22 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $530.16 | 2019-2022 | |
| Glaxosmithkline, LLC. | $327.84 | 2019-2024 | Nucala |
| Sun Pharmaceutical Industries INC. | $243.62 | 2019-2021 | |
| Alk-Abello, INC | $175.72 | 2019-2021 | |
| Amgen INC. | $166.32 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $164.03 | 2019-2021 | |
| Genzyme Corporation | $124.02 | 2019-2022 | |
| Janssen Biotech, INC. | $95.35 | 2020-2022 | |
| Leo Pharma INC. | $90.37 | 2020-2022 | |
| Genentech USA, INC. | $84.77 | 2019-2022 | |
| Organogenesis INC. | $82.06 | 2021 | |
| Sanofi-Aventis U.S. LLC | $72.00 | 2019 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Octapharma USA, INC. | $69.91 | 2021 | |
| Epi Health, LLC | $66.47 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $63.75 | 2019-2020 | |
| Galderma Laboratories, L.P. | $53.66 | 2020 | |
| Lilly USA, LLC | $52.50 | 2020-2021 | |
| Almirall LLC | $52.37 | 2020-2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $46.94 | 2020-2021 | |
| Incyte Corporation | $37.53 | 2021 | |
| Mayne Pharma Commercial LLC | $36.87 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $33.82 | 2021 | |
| Kaleo, INC. | $30.81 | 2019 | |
| Strata Skin Sciences, INC. | $24.27 | 2019 | |
| Jubilant Hollisterstier LLC | $20.94 | 2019 | |
| Dermira, INC. | $17.31 | 2020 | |
| Greer Laboratories, INC. | $17.09 | 2019 | |
| Journey Medical Corporation | $16.73 | 2022 | |
| Prugen, INC. Pharmaceuticals | $15.64 | 2020 | |
| Medtronic, INC. | $14.97 | 2024 | Arcpoint |
| Biocryst US Sales Co., LLC | $14.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Sullivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.